biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > MedImmune

<< Previous

Bullboard Posts

Next >>

Post by JDavenporton Nov 09, 2021 1:48am

638 Views

Post# 34103364

MedImmune

There have been questions about MedImmune raised on this forum since 2014. Where did they go? Why haven't they done anything with Bioasis after having such studies that were so successful that they put the results in a scientific paper.

Why don't they love me no more?

I've been wondering why MedImmune hasn't been mentioned here in the almost two weeks since the Bioasis/Daiichi Sankyo relationships were revealed in Bioasis's recent filings.

Does nobody remember that MedImmune was owned by AstraZeneca (AZ) until AZ shut the company down in 2019? As a result, AZ would have very good, first hand knowledge of Bioasis and xB3.

And then, of course, AZ partnered up with Daiichi Sankyo (DS) in the $6.9 billion Enhertu deal. And AZ claims to like conjugates.

And now Daichi Sankyo and Bioasis are buddies.

So, in the corner of the lab, is AZ watching what DS is doing with xB3? Is AZ involved? Is DS a proxy for AZ?

AZ probably knows more about xB3 than any other company. I don't know if they're involved in this latest stuff but we'd best get it on the record just in case. I don't believe a lot in coicidences in the secret worlds of drug development.

In the end, maybe we will get an answer to "What ever happened to MedImmune?"

Just speculating...

jd

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!